Skip to main content
. 2021 Oct 19;41(11):1173–1182. doi: 10.1002/cac2.12214

FIGURE 3.

FIGURE 3

Kaplan‐Meier curves of progression‐free survival and overall survival for the 125 Chinese patients with HER2‐overexpressing, locally advanced or metastatic gastric cancer treated with RC48. A, The estimated progression‐free survival in all patients was 4.1 months (95% CI, 3.7‐4.9 months). B, The estimated overall survival in all patients was 7.9 months (95% CI, 6.7‐9.9 months). Abbreviations: HER2 human epidermal growth factor receptor 2, CI confidence interval